Escherichia coli surface antigens

Escherichia coli surface antigens encompass a broad category of molecules located on the exterior of the E. coli bacterium, including lipopolysaccharides (O-antigens), capsular polysaccharides (K-antigens), flagellar proteins (H-antigens), and various adhesins or fimbriae (1). These antigens play a fundamental role in the pathogen's life cycle by facilitating attachment to host epithelial cells, enabling colonization, and providing a shield against the host's innate immune defenses (2). In medical research, these surface components are utilized as primary targets for vaccine development and monoclonal antibody therapies, particularly against extraintestinal pathogenic E. coli (ExPEC) and enterotoxigenic E. coli (ETEC) (3). By targeting these antigens, therapeutic interventions aim to elicit a robust immune response, typically through the production of opsonophagocytic antibodies that mark the bacteria for destruction by immune cells or by blocking the mechanical attachment of the bacteria to host tissues (4). However, the high degree of antigenic diversity among E. coli strains presents a significant challenge, often requiring multivalent formulations to achieve broad clinical protection (3). Furthermore, the presence of lipopolysaccharides necessitates careful purification or modification to avoid excessive inflammatory responses in patients (2). Overall, they represent a complex but vital set of targets for preventing a wide range of E. coli-mediated diseases (4). Sources: (1) CDC. "E. coli (Escherichia coli)". https://www.cdc.gov/ecoli/index.html; (2) Whitfield, C., & Trent, M. S. (2014). "Biosynthesis and export of bacterial lipopolysaccharides." Annual Review of Biochemistry; (3) Frenck, R. W., et al. (2019). "Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ExPEC4V)." Lancet Infectious Diseases; (4) Poolman, J. T., & Wacker, M. (2015). "Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development." Emerging Infectious Diseases.

Other names

E. coli surface proteinsEscherichia coli O-antigensE. coli capsular antigensBacterial surface antigensE. coli H-antigensE. coli fimbrial antigens

Induction of opsonophagocytic and neutralizing antibodies against bacterial surface components to prevent colonization and promote clearance.